Radcliffe Capital Management’s C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share CXAC.WS Stock Holding History

Radcliffe Capital Management’s Portfolio CXAC.WS Stock Details CXAC.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-395,528	Closed	-$12.7K	–	456
2023 Q3	$12.7K	Hold	395,528	–	–	﹤0.01%	319
2023 Q2	$19.5K	Hold	395,528	–	–	﹤0.01%	337
2023 Q1	$15.2K	Hold	395,528	–	–	﹤0.01%	467
2022 Q4	$4.04M	Hold	395,528	–	–	0.13%	252
2022 Q3	$3.97M	Buy	395,528 +20,800	+6%	+$3.5K	0.1%	369
2022 Q2	$3.74M	Hold	374,728	–	–	0.09%	403
2022 Q1	$3.71M	Buy	+374,728	New	+$123K	0.08%	380

Radcliffe Capital Management's CXAC.WS Position: Q4 2023 in Review

Radcliffe Capital Management sold out of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) in Q4 2023, closing a stake of 395,528 shares — an estimated $12.7K sold.

Radcliffe Capital Management first reported a position in CXAC.WS in Q1 2022 and held it in 7 quarters. The position peaked at $4.04M in Q4 2022. 0 funds tracked by Wall St. Rank hold CXAC.WS as of Q4 2023.

Radcliffe Capital Management reported no remaining C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2023 after selling out during the quarter.
Radcliffe Capital Management sold 395,528 C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2023, an estimated $12.7K.
Radcliffe Capital Management first reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q1 2022 and held it in 7 quarters.
Radcliffe Capital Management's C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $4.04M in Q4 2022.
0 funds tracked by Wall St. Rank held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.